NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease

Cell Reports

Volumn 7, Issue 6, 2014, Pages 1809-1814

  Ghadially, Hormas ^a   Ohana, Meir ^b   Elboim, Moran ^a   Gazit, Roi ^a   Gur, Chamutal ^a   Nagler, Arnon ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; LY ANTIGEN; NCR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COMMENSAL; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; GRAFT VERSUS HOST REACTION; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; PROCEDURES; TRANSGENIC MOUSE;

ANIMALIA;

ANIMALS; ANTIGENS, LY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

EID: 84903488082     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.011     Document Type: Article

References (29)

1. Biassoni R., Pessino A., Bottino C., Pende D., Moretta L., Moretta A. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 1999, 29:1014-1020.
2. Ferlazzo G., Semino C., Melioli G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 2001, 76:37-41.
3. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J.Exp. Med. 2002, 195:343-351.
4. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006, 7:517-523.
5. Ghadially H., Horani A., Glasner A., Elboim M., Gazit R., Shoseyov D., Mandelboim O. NKp46 regulates allergic responses. Eur. J. Immunol. 2013, 43:3006-3016.
6. Halfteck G.G., Elboim M., Gur C., Achdout H., Ghadially H., Mandelboim O. Enhanced invivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J.Immunol. 2009, 182:2221-2230.
7. Ilan Y., Ohana M., Pappo O., Margalit M., Lalazar G., Engelhardt D., Rabbani E., Nagler A. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Transplantation 2007, 83:458-467.
8. Jonsson A.H., Yokoyama W.M. Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 2009, 101:27-79.
9. Koka R., Burkett P., Chien M., Chai S., Boone D.L., Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J.Immunol. 2004, 173:3594-3598.
10. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26:503-517.
11. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009, 10:75-82.
12. Lutz M.B., Kukutsch N., Ogilvie A.L., Rössner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J.Immunol. Methods 1999, 223:77-92.
13. Narni-Mancinelli E., Jaeger B.N., Bernat C., Fenis A., Kung S., De Gassart A., Mahmood S., Gut M., Heath S.C., Estellé J., et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates Tcell responses. Science 2012, 335:344-348.
14. Olson J.A., Leveson-Gower D.B., Gill S., Baker J., Beilhack A., Negrin R.S. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive Tcells while retaining GVT effects. Blood 2010, 115:4293-4301.
15. Pérez-Simón J.A., Sánchez-Abarca I., Díez-Campelo M., Caballero D., San Miguel J. Chronic graft-versus-host disease: Pathogenesis and clinical management. Drugs 2006, 66:1041-1057.
16. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
17. Ruggeri L., Aversa F., Martelli M.F., Velardi A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol. Rev. 2006, 214:202-218.
18. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009, 10:83-91.
19. Satoh-Takayama N., Dumoutier L., Lesjean-Pottier S., Ribeiro V.S., Mandelboim O., Renauld J.C., Vosshenrich C.A., Di Santo J.P. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J.Immunol. 2009, 183:6579-6587.
20. Shlomchik W.D. Graft-versus-host disease. Nat. Rev. Immunol. 2007, 7:340-352.
21. Shlomchik W.D., Couzens M.S., Tang C.B., McNiff J., Robert M.E., Liu J., Shlomchik M.J., Emerson S.G. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
22. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L., Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 1999, 29:1656-1666.
23. Sivori S., Parolini S., Marcenaro E., Castriconi R., Pende D., Millo R., Moretta A. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J.Neuroimmunol. 2000, 107:220-225.
24. Sivori S., Parolini S., Marcenaro E., Millo R., Bottino C., Moretta A. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum. Immunol. 2000, 61:1055-1058.
25. Spaggiari G.M., Carosio R., Pende D., Marcenaro S., Rivera P., Zocchi M.R., Moretta L., Poggi A. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 2001, 31:1656-1665.
26. Vallance B.A., Deng W., Jacobson K., Finlay B.B. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 2003, 71:3443-3453.
27. Vitale M., Della Chiesa M., Carlomagno S., Pende D., Aricò M., Moretta L., Moretta A. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005, 106:566-571.
28. Weiss L., Reich S., Mandelboim O., Slavin S. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy. Bone Marrow Transplant. 2004, 33:1137-1141.
29. Yu G., Xu X., Vu M.D., Kilpatrick E.D., Li X.C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J.Exp. Med. 2006, 203:1851-1858.